Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mechanistic Models: Compartment Models in Individual and Population Analysis01:23

Mechanistic Models: Compartment Models in Individual and Population Analysis

Mechanistic models are utilized in individual analysis using single-source data, but imperfections arise due to data collection errors, preventing perfect prediction of observed data. The mathematical equation involves known values (Xi), observed concentrations (Ci), measurement errors (εi), model parameters (ϕj), and the related function (ƒi) for i number of values. Different least-squares metrics quantify differences between predicted and observed values. The ordinary least squares (OLS)...
Mechanistic Models: Compartment Models in Algorithms for Numerical Problem Solving01:29

Mechanistic Models: Compartment Models in Algorithms for Numerical Problem Solving

Mechanistic models play a crucial role in algorithms for numerical problem-solving, particularly in nonlinear mixed effects modeling (NMEM). These models aim to minimize specific objective functions by evaluating various parameter estimates, leading to the development of systematic algorithms. In some cases, linearization techniques approximate the model using linear equations.
In individual population analyses, different algorithms are employed, such as Cauchy's method, which uses a...
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
Pharmacodynamic Models: Additive and Proportional Drug Effect Model01:09

Pharmacodynamic Models: Additive and Proportional Drug Effect Model

Drug response models describe how pharmacological agents interact with biological systems to produce measurable effects. Baseline responses are inherent physiological activities without a drug significantly influencing the observed pharmacological outcomes. Depending on the drug response model employed, these baseline responses may combine with the drug's effect in either an additive or proportional manner.Additive Drug Response ModelIn the additive model, the drug effect is independent of the...
Methods of Medium Optimization01:28

Methods of Medium Optimization

Optimizing growth media enhances microbial proliferation and maximizes product yield. Statistical experimental design methodologies provide structured and reproducible approaches, offering progressively higher levels of robustness and efficiency.The One-Factor-at-a-Time (OFAT) MethodThe One-Factor-at-a-Time (OFAT) method involves adjusting a single variable while keeping all others constant. However, it cannot detect interactions between variables, often leading to suboptimal outcomes when...
One-Compartment Open Model: Wagner-Nelson and Loo Riegelman Method for ka Estimation01:24

One-Compartment Open Model: Wagner-Nelson and Loo Riegelman Method for ka Estimation

This lesson introduces two critical methods in pharmacokinetics, the Wagner-Nelson and Loo-Riegelman methods, used for estimating the absorption rate constant (ka) for drugs administered via non-intravenous routes. The Wagner-Nelson method relates ka to the plasma concentration derived from the slope of a semilog percent unabsorbed time plot. However, it is limited to drugs with one-compartment kinetics and can be impacted by factors like gastrointestinal motility or enzymatic degradation.
On...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Unveiling the conversion mechanism of glioblastoma from the mesenchymal to the proneural subtype driven by HDAC1/p-SMAD3-TP53I11 axis.

Translational oncology·2026
Same author

Treatment of High-Risk Idiopathic Membranous Nephropathy with Huaier Granules and RASi: A Case Series.

International medical case reports journal·2026
Same author

Med-Diet: evaluation of an LLM-based system for clinically guided nutrition care in chronic diseases.

Frontiers in nutrition·2026
Same author

A pathological morphology parameter-based prognostic nomogram for high-risk prostate cancer patients treated with neoadjuvant therapy followed by radical prostatectomy: a retrospective study.

World journal of surgical oncology·2026
Same author

[Comparison of Imaging Efficacy and Patient Tolerability Between a Novel Cellulose-Based anda Conventional Starch-Based Oral Contrast Agent: A Prospective Randomized Controlled Trial].

Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae·2026
Same author

Author Correction: Hospital information system based psychological nursing improves maternal and neonatal outcomes in cesarean section patients.

Scientific reports·2026

Related Experiment Video

Updated: Jun 16, 2026

Development of an Individual-Tree Basal Area Increment Model using a Linear Mixed-Effects Approach
04:35

Development of an Individual-Tree Basal Area Increment Model using a Linear Mixed-Effects Approach

Published on: July 3, 2020

GENERALIZED PARTIALLY LINEAR MIXED-EFFECTS MODELS INCORPORATING MISMEASURED COVARIATES.

Hua Liang1

  • 1Department of Biostatistics and Computational Biology, University of Rochester, Rochester, NY 14642, USA.

Annals of the Institute of Statistical Mathematics
|February 18, 2010
PubMed
Summary

This study introduces a new statistical model for analyzing longitudinal data, improving estimations in complex health studies like AIDS clinical trials by accounting for local data correlations and measurement errors.

Related Experiment Videos

Last Updated: Jun 16, 2026

Development of an Individual-Tree Basal Area Increment Model using a Linear Mixed-Effects Approach
04:35

Development of an Individual-Tree Basal Area Increment Model using a Linear Mixed-Effects Approach

Published on: July 3, 2020

Area of Science:

  • Statistics
  • Biostatistics
  • Longitudinal Data Analysis

Background:

  • Longitudinal data analysis is crucial for understanding health trends over time.
  • Mixed-effects models are commonly used but have limitations with complex data structures.
  • Semiparametric models offer flexibility but require advanced estimation techniques.

Purpose of the Study:

  • To develop a semiparametric generalized mixed-effects model for longitudinal data.
  • To estimate population and individual parameters and nonparametric curves accurately.
  • To address challenges like local correlation structures and measurement errors in covariates.

Main Methods:

  • Combining local linear regression with penalized quasilikelihood and local quasilikelihood.
  • Developing estimators that consider the local correlation structure of data.
  • Establishing theoretical properties (normality, asymptotic expansion) for the estimators.
  • Proposing an algorithm for practical implementation and addressing measurement error.

Main Results:

  • The proposed estimators provide accurate estimations for both parametric and nonparametric components.
  • The methods successfully account for local correlation structures in longitudinal data.
  • A strategy for adjusting measurement errors in covariates was developed and validated.
  • The model was successfully applied to analyze AIDS clinical trial data.

Conclusions:

  • The developed semiparametric generalized mixed-effects model offers a robust framework for analyzing complex longitudinal health data.
  • The proposed methods provide reliable parameter and curve estimations, even with local correlations and measurement errors.
  • This approach enhances the analysis of clinical trials, particularly in understanding disease progression and treatment efficacy.